Opus Genetics (IRD) Notes Payables (2019 - 2025)

Opus Genetics (IRD) has 5 years of Notes Payables data on file, last reported at $21.3 million in Q3 2025.

• On a quarterly basis, Notes Payables changed N/A year-over-year to $21.3 million in Q3 2025; TTM through Sep 2025 was $21.3 million, a N/A change from a year earlier, with the FY2024 full-year figure at $2.0 million, up 2602.7% from the prior year.
• Notes Payables for Q3 2025 stood at $21.3 million, up from $11.8 million in the prior quarter.
• Over the last five years, Notes Payables for IRD reached as high as $21.3 million in Q3 2025 and fell as low as $74000.0 in Q4 2023.
• Historically, Notes Payables has averaged $5.4 million across 4 years, with a median of $215000.0 in 2022.
• Across the five-year window, Notes Payables surged 2602.7% in 2024 and soared 17082.43% in 2025, its largest moves.
• Year by year, Notes Payables stood at $215000.0 in 2022, then tumbled by 65.58% to $74000.0 in 2023, then surged by 2602.7% to $2.0 million in 2024, then jumped by 966.25% to $21.3 million in 2025.
• Per Business Quant data, the three most recent Notes Payables figures were $21.3 million in Q3 2025, $11.8 million in Q2 2025, and $12.7 million in Q1 2025.